Cannabinoid formulations for inhalation
US10588870B2 · kind B2 · utility
0Cited by
15References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2018 |
| Grant date | Mar 17, 2020 |
| Priority date | — |
| Expiry date | Jul 25, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61M11/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A cannabinoid active agent containing formulation comprising the active agent, an HFA propellant, optionally a terpenoid, and optionally a co-solvent is disclosed. At least two cannabinoids, each of which is required to be present in amounts of at least 20% of the total cannabinoid content of formulation are required to be present. Also disclosed is an inhalation method of administration of the formulation without the use of heat greater than 40° C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.